BTSA9

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark BTSA9 was filed as Word mark on 09/17/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/19/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 018561390
Application date September 17, 2021
Publication date October 12, 2021
Entry date January 19, 2022
Expiration date September 17, 2031

Trademark owner

94, Jeyakgongdan 4-gil Hyangnam-eup
18622 Hwaseong-si, Gyeonggi-do
KR

Trademark representatives

Bajuwarenring 14 82041 München DE

goods and services

5 Pharmaceutical preparations for treatment of convulsion; therapeutic injectable pharmaceuticals for muscles; preparations for treatment of sarcopenia; pharmaceutical preparations for treatment of cerebral palsy; pharmaceutical preparations for treatment of hyperhidrosis; pharmaceutical preparations for treatment of headache; pharmaceutical preparations for treatment of trembling disorder; pharmaceutical preparations for treatment of neurological disorder; injectable pharmaceuticals for treatment of ligaments; pharmaceutical preparations for treatment of autonomic nervous system disease; pharmaceutical preparations for treatment of wrinkly skin syndrome; analgesics; injectable pharmaceuticals for treatment of tendon; pharmaceutical preparations including Botulinum toxin; pharmaceutical preparations for treatment of smooth muscle disease; pharmaceutical preparations for treating myotonia; pharmaceutical preparations for treating sports injuries; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting peripheral nervous system; adjuvants for medical purposes; drugs for medical purposes; pharmaceutical preparations for central nerve treatment; pharmaceutical preparations for chemical disorder treatment; pharmaceutical preparations for diagnosis; chemicals for pharmaceutical use; medicines for human purposes

Trademark history

Date Document number Area Entry
July 24, 2024 Change Representative, Published
December 1, 2023 Transfer / Change of address, Published

ID: 11018561390